Institutional
27 de July de 2017
São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending
Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
Click on Download to access the full text of the decision.
Back
Share:
Last related news
10 de February de 2026
Kasznar Leonardos was ranked in 2025 Outstanding International IP Service Teams
We are honored to announce that, for the second year in a row, we have been recognized in the “Outstanding International IP … Kasznar Leonardos was ranked in 2025 Outstanding International IP Service Teams
28 de January de 2026
Kasznar Leonardos is ranked on WTR 1000 2026
We are honored to announce that Kasznar Leonardos has been ranked as a reference firm in the Trademarks area, Gold category, by … Kasznar Leonardos is ranked on WTR 1000 2026
13 de November de 2025
Kasznar Leonardos is ranked by Best Lawyers 2026
We are honored to announce that Kasznar Leonardos has been recognized as Intellectual Property Firm of the Year by Best Lawyers Brazil … Kasznar Leonardos is ranked by Best Lawyers 2026